15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 7.8% per year over the past 5 years.
Net income has grown slower than revenue (7.2% vs 7.8% per year).
Operating margin has expanded, at 21.2% in the latest year.
Financial health
Total debt ($50.0B) exceeds cash ($626M); net debt is $49.4B.
Total debt has grown in line with revenue (5.6% vs 7.8% per year).
Total debt is 5.7× EBITDA.
Shareholder returns
Dividends have been paid for 15 consecutive years, consuming 58.4% of earnings.
The dividend has grown 1.6% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$24.3B
$2.8B
0.0%
21.2%
-$2.3B
$50.0B
$626M
2024
$23.0B
$2.5B
0.0%
18.8%
-$1.5B
$46.5B
$357M
2023
$21.7B
$2.3B
0.0%
18.5%
-$2.7B
$43.8B
$445M
2022
$19.1B
$2.2B
0.0%
17.4%
-$2.3B
$39.8B
$407M
2021
$17.9B
$1.8B
0.0%
15.0%
-$5.0B
$33.9B
$672M
2020
$16.7B
$2.0B
0.0%
13.1%
-$3.8B
$38.1B
$432M
2019
$16.7B
$3.0B
0.0%
15.9%
-$589M
$37.3B
$587M
2018
$36.0B
$2.1B
0.0%
10.8%
$1.1B
$36.0B
$1.3B
2017
$33.6B
$3.9B
0.0%
13.1%
-$104M
$35.0B
$898M
2016
$31.4B
$1.2B
0.0%
10.2%
-$92M
$35.2B
$635M
2015
$29.4B
$2.3B
0.0%
15.0%
-$8M
$26.3B
$6.5B
2014
$27.4B
$1.8B
0.0%
11.3%
-$1.6B
$21.9B
$1.9B
2013
$24.9B
$1.7B
0.0%
14.7%
$948M
$19.7B
$1.6B
2012
$23.5B
$1.2B
0.0%
10.1%
$342M
$18.9B
$1.5B
2011
$19.1B
$2.5B
0.0%
23.5%
$811M
$13.2B
$1.0B
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$7.2B
$919M
0.0%
22.2%
-$634M
$48.5B
$713M
Dec '25
$5.4B
$594M
0.0%
21.9%
-$1.2B
$50.0B
$626M
Sep '25
$6.7B
$875M
0.0%
22.4%
$163M
$47.4B
$1.5B
Jun '25
$5.4B
$391M
0.0%
17.1%
-$502M
$46.6B
$724M
Mar '25
$6.7B
$908M
0.0%
22.9%
-$746M
$46.4B
$1.0B
Dec '24
$5.5B
$647M
0.0%
20.1%
-$510M
$46.5B
$357M
Sep '24
$6.2B
$707M
0.0%
19.4%
-$6M
$44.7B
$616M
Jun '24
$5.4B
$448M
0.0%
17.0%
-$237M
$44.5B
$934M
Mar '24
$6.0B
$658M
0.0%
18.4%
-$775M
$44.5B
$720M
Dec '23
$5.4B
$617M
0.0%
20.3%
-$457M
$43.8B
$445M
Sep '23
$6.0B
$700M
0.0%
18.8%
-$324M
$41.2B
$300M
Jun '23
$4.8B
$343M
0.0%
14.6%
-$527M
$40.7B
$399M
Mar '23
$5.6B
$669M
0.0%
19.9%
-$1.4B
$40.0B
$522M
Dec '22
$4.7B
$432M
0.0%
15.2%
-$1.2B
$39.8B
$407M
Sep '22
$4.8B
$676M
0.0%
20.9%
-$771M
$37.0B
$446M
Jun '22
$4.2B
$465M
0.0%
16.4%
-$127M
$37.8B
$816M
Mar '22
$5.3B
$598M
0.0%
16.9%
-$140M
$36.9B
$2.5B
Dec '21
$4.4B
$388M
0.0%
11.8%
-$3.1B
$33.9B
$672M
Sep '21
$4.9B
$1.2B
0.0%
15.5%
$1.1B
$37.9B
$3.0B
Jun '21
$4.0B
$476M
0.0%
14.4%
$499M
$36.9B
$1.6B
Valuation over time
How the market has priced EXC against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 19.7× (Mar '23) to 17.3× (Jun '26).
The price-to-sales ratio has fallen from 2.2× (Mar '23) to 2.0× (Jun '26).
The dividend yield has risen from 3.1% (Mar '23) to 3.4% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is EXC growing its revenue and profit?
Over the past 5 years, Exelon's revenue has grown 7.8% per year, and net income grown 7.2% per year. These are computed facts, not advice.
How much debt does EXC have?
As of FY2025, Exelon reported $50.0B of total debt against $626M of cash.
What is EXC's profit margin?
In FY2025, gross margin was —, operating margin 21.2%, and net margin 11.4%.
What is EXC's P/E ratio?
As of Jun '26, Exelon traded at a price-to-earnings ratio of about 17.3× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.